The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
Open accessAbstract
B cells have paradoxical roles in autoimmunity, exerting both pathogenic and protective effects. Pathogenesis may be antibody independent, as B cell depletion therapy (BCDT) leads to amelioration of disease irrespective of autoantibody ablation. However, the mechanisms of pathogenesis are poorly understood. We demonstrate that BCDT alleviates central nervous system autoimmunity through ablation of IL-6–secreting pathogenic B cells. B cells from mice with experimental autoimmune encephalomyelitis (EAE) secreted elevated levels of IL-6 compared with B cells from naive controls, and mice with a B cell–specific IL-6 deficiency showed less severe disease than mice with wild-type B cells. Moreover, BCDT ameliorated EAE only in mice with IL-6–sufficient B cells. This mechanism of pathogenesis may also operate in multiple sclerosis (MS) because B cells from MS patients produced more IL-6 than B cells from healthy controls, and this abnormality was normalized with B cell reconstitution after Rituximab treatment. This suggests that BCDT improved disease progression, at least partly, by eliminating IL-6–producing B cells in MS patients. Taking these data together, we conclude that IL-6 secretion is a major mechanism of B cell–driven pathogenesis in T cell–mediated autoimmune disease such as EAE and MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Self-citationToll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Self-citationBlair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Yanaba, K., Bouaziz, J.-D., Haas, K. M., Poe, J. C., Fujimoto, M., & Tedder, T. F. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.017 · Cited by 1,238
BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells
O'Connor, B. P., Raman, V. S., Erickson, L. D., Cook, W. J., Weaver, L. K., Ahonen, C., Lin, L.-L., Mantchev, G. T., Bram, R. J., & Noelle, R. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031330 · Cited by 1,128
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Matsushita, T., Yanaba, K., Bouaziz, J.-D., Fujimoto, M., & Tedder, T. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36030 · Cited by 913
Prevention of Arthritis by Interleukin 10–producing B Cells
Mauri, C., Gray, D., Mushtaq, N., & Londei, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021293 · Cited by 860
Self-citationDuddy, M., Niino, M., Adatia, F., Hebert, S., Freedman, M., Atkins, H., Kim, H. J., & Bar-Or, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6092 · Cited by 653
Self-citationBalázs, M., Martin, F., Zhou, T., & Kearney, J. F. (2002) · Immunity · doi:10.1016/s1074-7613(02)00389-8 · Cited by 624
Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V., & Segal, B. M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080159 · Cited by 579
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Neurath, M. F., & Finotto, S. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.02.003 · Cited by 576
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial
Bar‐Or, A., Calabresi, P. A. J., Arnold, D., Markowitz, C., Shafer, S., Kasper, L. H., Waubant, E., Gazda, S., Fox, R. J., Panzara, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21363 · Cited by 527
Self-citationAbnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?
Bar‐Or, A., Fawaz, L., Fan, B., Darlington, P. J., Rieger, A., Ghorayeb, C., Calabresi, P. A., Waubant, E., Hauser, S. L., Zhang, J., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21939 · Cited by 521
Self-citationB-cell targeting in rheumatoid arthritis and other autoimmune diseases
Edwards, J. C. W., & Cambridge, G. (2006) · Nature Reviews Immunology · doi:10.1038/nri1838 · Cited by 507
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Cross, A. H., Stark, J. L., Lauber, J., Ramsbottom, M. J., & Lyons, J.-A. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.06.029 · Cited by 454
MacLeod (2008) · Bristol Research (University of Bristol) · doi:10.4049/jimmunol · Cited by 448
Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T.-S. T., & Chen, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6480 · Cited by 440
TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity
Lampropoulou, V., Hoehlig, K., Roch, T., Neves, P., Gómez, E. C., Sweenie, C. H., Hao, Y., Freitas, A. A., Steinhoff, U., Anderton, S. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4763 · Cited by 436 · cited 13×
“However, the production of IL-10 in mice (Lampropoulou et al., 2008; Barr et al., 2010; Neves et al., 2010) and humans (Bouaziz et al., 2010) is strongly augmented by TLR signals and, indeed, these innate signals are required in vivo for the full expression of regulatory activity (Lampropoulou et…”
BackgroundMethodResultInfluentialSelf-citationIL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice
Haak, S., Croxford, A. L., Kreymborg, K., Heppner, F. L., Pouly, S., Becher, B., & Waisman, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35997 · Cited by 399
B CELL IMMUNOBIOLOGY IN DISEASE: Evolving Concepts from the Clinic
Martin, F., & Chan, A. C. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090517 · Cited by 369
Belnoue, E., Pihlgren, M., McGaha, T. L., Tougne, C., Rochat, A.-F., Bossen, C., Schneider, P., Huard, B., Lambert, P.-H., & Siegrist, C.-A. (2008) · Blood · doi:10.1182/blood-2007-09-110858 · Cited by 364
O'Connor, R. A., Prendergast, C. T., Sabatos, C. A., Lau, C. W. Z., Leech, M. D., Wraith, D. C., & Anderton, S. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3750 · Cited by 350
Self-citationSerada, S., Fujimoto, M., Mihara, M., Koike, N., Ohsugi, Y., Nomura, S., Yoshida, H., Nishikawa, T., Terabe, F., Ohkawara, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802218105 · Cited by 349
The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
Oksenberg, J. R., Baranzini, S. E., Sawcer, S., & Hauser, S. L. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2395 · Cited by 347
Mann, M. K., Maresz, K., Shriver, L. P., Tan, Y., & Dittel, B. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3447 · Cited by 316
Neves, P., Lampropoulou, V., Calderon-Gomez, E., Roch, T., Stervbo, U., Shen, P., Kühl, A. A., Loddenkemper, C., Haury, M., Nedospasov, S. A., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.016 · Cited by 308
Self-citationNot always the bad guys: B cells as regulators of autoimmune pathology
Fillatreau, S., Gray, D., & Anderton, S. M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2315 · Cited by 295
Self-citationTLR‐mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells
Barr, T. A., Brown, S., Ryan, G., Zhao, J., & Gray, D. (2007) · European Journal of Immunology · doi:10.1002/eji.200636483 · Cited by 281
Self-citationGood, K. L., Bryant, V. L., & Tangye, S. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5236 · Cited by 279
IL‐10 produced by activated human B cells regulates CD4+ T‐cell activation in vitro
Bouaziz, J., Calbo, S., Maho‐Vaillant, M., Saussine, A., Bagot, M., Bensussan, A., & Musette, P. (2010) · European Journal of Immunology · doi:10.1002/eji.201040673 · Cited by 237
Zhou, D., Srivastava, R., Nessler, S., Grummel, V., Sommer, N., Brück, W., Hartung, H.-P., Stadelmann, C., & Hemmer, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607242103 · Cited by 231
Okuda, Y. (1998) · International Immunology · doi:10.1093/intimm/10.5.703 · Cited by 229
IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Zepp, J., Wu, L., & Li, X. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.007 · Cited by 224
Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes.
Burdin, N., Van Kooten, C., Galibert, L., Abrams, J. S., Wijdenes, J., Banchereau, J., & Rousset, F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2533 · Cited by 198
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid
Owens, G. P., Bennett, J. L., Lassmann, H., O'Connor, K. C., Ritchie, A. M., Shearer, A., Lam, C., Yu, X., Birlea, M., DuPree, C., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21641 · Cited by 188
Interleukin‐6 functions in autoimmune encephalomyelitis: a study in gene‐targeted mice
Mendel, I., Katz, A., Kozak, N., Ben‐Nun, A., & Revel, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199805)28:05<1727::aid-immu1727>3.0.co;2-# · Cited by 162
Barr, T. A., Brown, S. L., Mastroeni, P., & Gray, D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001431 · Cited by 144
Self-citationLampropoulou, V., Calderon‐Gomez, E., Roch, T., Neves, P., Shen, P., Stervbo, U., Boudinot, P., Anderton, S. M., & Fillatreau, S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00855.x · Cited by 130
Self-citationAtacicept: targeting B cells in multiple sclerosis
Hartung, H., & Kieseier, B. C. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610371146 · Cited by 129
B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
Kala, M., Rhodes, S., Piao, W., Shi, F.-D., Campagnolo, D., & Vollmer, T. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.10.015 · Cited by 105
B Cells as a Therapeutic Target for IFN-β in Relapsing–Remitting Multiple Sclerosis
Ramgolam, V. S., Sha, Y., Marcus, K. L., Choudhary, N. R., Troiani, L., Chopra, M., & Markovic‐Plese, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000271 · Cited by 88
Activated B cells in autoimmune diseases: the case for a regulatory role
Anderton, S. M., & Fillatreau, S. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0950 · Cited by 60
Self-citationCognasse, F., Hamzeh‐Cognasse, H., Lafarge, S. T., Chavarin, P., Pozzetto, B., Richard, Y., & Garraud, O. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02844.x · Cited by 40
Fillatreau, S., & Anderton, S. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.4.565 · Cited by 12
Self-citationThe TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2
Eugster (1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1521-4141(199807)28:07 · Cited by 2
Cited by
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Self-citationvon Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Kamisawa, T., Zen, Y., Pillai, S., & Stone, J. H. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60720-0 · Cited by 1,212
Metadata
- Authors
- Barr, T. A., Shen, P., Brown, S., Lampropoulou, V., Roch, T., Lawrie, S., Fan, B., O’Connor, R. A., Anderton, S. M., Bar-Or, A., Fillatreau, S., & Gray, D.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2012-04-30
- Volume
- 209
- Issue
- 5
- Pages
- 1001-1010
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2154132418
- Cited by
- 649
- References
- 50
- FWCI
- 36.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.